Indicaton

Invasive aspergillosis and mucormycosis

Therapeutic indications
Type of product
Table
  • Phase

    Marketed

  • Partnering status

    Partnered

  • Partner

    Astellas for U.S.; Pfizer for Europe (excl. Nordics), China, Asia-Pacific, Israel, Russia, Turkey; Unimedic for Nordics; Asahi Kasei Pharma for Japan; Hikma for MENA region; Grupo Biotoscana for Latin America; Avir for Canada

  • Available in

    U.S. and EU and several international markets

You may also be interested in